NGN CAPITAL LLC
NGN CAPITAL LLC is a Seed, Series A, Series B and Series C+ fund in the US, Europe and Israel writing $22.2M–$31.1M checks into healthcare-tech, biotechnology, drug-products, medical-devices and healthcare-services.
- Stages
- Seed, Series A, Series B, Series C+
- Sectors
- healthcare-tech, biotechnology, drug-products, medical-devices, healthcare-services
- Check size
- $22.2M–$31.1M
- Invests in
- US-wide, Europe, Israel
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2003
- Assets under management
- $125M
- Website
- ngncapital.com
Thesis
NGN Capital LLC is a venture capital firm founded in 2003 that invests in the healthcare and biotechnology sectors, including drug products, medical devices, and healthcare services. The firm targets later-stage opportunities but also considers early-stage investments. NGN Capital has a global scope, focusing primarily on the United States and Europe, with consideration for Israel. Their strategy aims for above-average private equity returns through diversification and active management. The firm has managed two main funds, NGN BioMed Opportunity I and II, with the former closing at $250 million. As of March 2015, AUM was reported at $189.6 million, and more recently at $125 million. NGN Capital often leads investment rounds, typically in Series B, A, and C stages, with check sizes ranging from $22.2 million to $31.1 million. They have a track record of 58 investments, including 3 IPOs and 17 acquisitions.
Common questions
Does NGN CAPITAL LLC invest at the Seed stage?
Yes. NGN CAPITAL LLC lists Seed, Series A, Series B and Series C+ among the stages it invests in.
What check size does NGN CAPITAL LLC write?
NGN CAPITAL LLC writes $22.2M–$31.1M checks.
Where does NGN CAPITAL LLC invest?
NGN CAPITAL LLC invests in the US, Europe and Israel.